VesselSens develops an implantable sensor system for real-time wireless detection of restenosis in coronary and peripheral arteries, enabling immediate data transmission to healthcare providers. This technology facilitates timely intervention, significantly reducing the risk of complications associated with arterial blockages and minimizing the need for extensive follow-up examinations.
Funding
$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Post-stent restenosis, the re-narrowing of an artery after stent implantation or angioplasty, often goes undetected until significant blockage occurs, leading to complications and the need for frequent, invasive follow-up procedures. Current diagnostic methods are often time-consuming, expensive, and may not provide continuous monitoring of arterial health.
Solution
VesselSens has developed an implantable sensor system designed for real-time, wireless detection of restenosis in coronary and peripheral arteries. The system consists of an implantable sensor that is placed in the artery during stent implantation or balloon angioplasty. A separate readout device, placed on the body near the implant, wirelessly acquires data from the sensor and transmits it to a secure cloud service. Proprietary algorithms analyze the data to calculate the degree of restenosis and relay the results back to the cardiologist or physician within minutes. Clinicians can also access the data via a web interface to monitor trends and other vital parameters related to restenosis.
Target Audience
The primary target audience includes cardiologists, interventional radiologists, and patients at risk of restenosis following stent implantation or angioplasty procedures.
Features
- Implantable sensor for continuous monitoring of arterial narrowing
- Wireless data transmission to an external readout device
- Cloud-based data analysis and reporting
- Web interface for clinicians to access patient-specific data and trends
- Early prediction of clogging
- Measurements in short intervals
- The restenosis treatment may be induced in an earlier stage
- Success of therapy is detectable and can be monitored